Sunesis Pharmaceuticals (FRA:RYIS) Market Cap : €63.71 Mil (As of May. 25, 2024)

View and export this data going back to 2007. Start your Free Trial

What is Sunesis Pharmaceuticals Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Sunesis Pharmaceuticals's share price for the quarter that ended in Dec. 2020 was €5.23. Sunesis Pharmaceuticals's Shares Outstanding (EOP) for the quarter that ended in Dec. 2020 was 18.11 Mil. Therefore, Sunesis Pharmaceuticals's market cap for the quarter that ended in Dec. 2020 was €94.71 Mil.

Sunesis Pharmaceuticals's quarterly market cap declined from Jun. 2020 (€89.73 Mil) to Sep. 2020 (€70.02 Mil) but then increased from Sep. 2020 (€70.02 Mil) to Dec. 2020 (€94.71 Mil).

Sunesis Pharmaceuticals's annual market cap increased from Dec. 2018 (€43.43 Mil) to Dec. 2019 (€124.76 Mil) but then declined from Dec. 2019 (€124.76 Mil) to Dec. 2020 (€94.71 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Sunesis Pharmaceuticals's Enterprise Value for Today is €63.71 Mil.

Sunesis Pharmaceuticals Market Cap Historical Data

The historical data trend for Sunesis Pharmaceuticals's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunesis Pharmaceuticals Market Cap Chart

Sunesis Pharmaceuticals Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Market Cap

Get a 7-Day Free Trial

246.66

357.79

43.43

124.76

94.71

Sunesis Pharmaceuticals Quarterly Data
	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20
Market Cap	Get a 7-Day Free Trial															124.76	139.58	89.73	70.02	94.71

Competitive Comparison of Sunesis Pharmaceuticals's Market Cap

For the Biotechnology subindustry, Sunesis Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sunesis Pharmaceuticals's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sunesis Pharmaceuticals's Market Cap distribution charts can be found below:

* The bar in red indicates where Sunesis Pharmaceuticals's Market Cap falls into.

Sunesis Pharmaceuticals Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Sunesis Pharmaceuticals's Market Cap for the fiscal year that ended in Dec. 2020 is calculated as

Market Cap (A: Dec. 2020 )	=	Share Price (A: Dec. 2020 )	*	Shares Outstanding (EOP) (A: Dec. 2020 )
	=	€5.23	*	18.1083
	=	€94.71

Sunesis Pharmaceuticals's Market Cap for the quarter that ended in Dec. 2020 is calculated as

Market Cap (Q: Dec. 2020 )	=	Share Price (Q: Dec. 2020 )	*	Shares Outstanding (EOP) (Q: Dec. 2020 )
	=	€5.23	*	18.1083
	=	€94.71

Sunesis Pharmaceuticals (FRA:RYIS) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Sunesis Pharmaceuticals Market Cap Related Terms

Thank you for viewing the detailed overview of Sunesis Pharmaceuticals's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Sunesis Pharmaceuticals (FRA:RYIS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sunesis Pharmaceuticals Inc (FRA:RYIS) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

395 Oyster Point Boulevard, Suite 400, South San Francisco, CA, USA, 94080

Website

http://www.sunesis.com

Sunesis Pharmaceuticals Inc is a US-based biopharmaceutical company. It focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers. The product portfolio of the company includes Vosaroxin which is an anticancer quinolone derivative for the treatment of acute myeloid leukemia (AML). The company's other kinase inhibitor pipeline includes TAK-580, SNS-062, and SNS-229. Further, the firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The firm derives substantially the majority of revenue from license and collaboration agreements.

Sunesis Pharmaceuticals (FRA:RYIS) Headlines

No Headlines